

![]() |
|||||||||||||
|
| All | Since 2020 | |
| Citation | 6651 | 4087 |
| h-index | 26 | 21 |
| i10-index | 174 | 83 |
Search
News & Updation
DAPAGLIFLOZIN AND METOPROLOL BOTH COMBINATION DRUGS USED IN TREATMENT OF HEART FAILURE
Nidhi Tadvi*, Krishna Kalsara and Dr. Umesh Upadhyay
ABSTRACT Based on the results from dedicated cardiovascular outcome trials (CVOTs), current guidelines suggest the use of SGLT-2 inhibitors for patients with T2DM and established atherosclerotic cardiovascular disease (ASCVD) or heart failure. Keywords: Heart failure, dapagliflozin, metoprolol. [Download Article] [Download Certifiate] |
